Informed consent
|
X
| | | | | | | |
Demographics
|
X
| | | | | | | |
Medical history
|
X
|
X
|
X
|
X
|
X
|
X
|
X
|
X
|
Medications
|
X
|
X
|
X
|
X
|
X
|
X
|
X
|
X
|
Physical examination
|
X
|
X
|
X
|
X
|
X
|
X
|
X
|
X
|
Routine blood tests (FBC, U&Es, LFTs, CRP and eGFR)
|
X
|
X
|
X
|
X
|
X
|
X
|
X
|
X
|
Immunology (RF, ACPA, ANA)
|
X
| | | | | | | |
Radiographs of hands/feet/spine
|
X
| | | |
X
| |
X
|
X
|
Eligibility assessment
|
X
| | | | | | | |
Adherence
| |
X
|
X
|
X
|
X
|
X
|
X
|
X
|
68/66 Joint count
|
X
|
X
|
X
|
X
|
X
|
X
|
X
|
X
|
Leeds and SPARCC enthesitis index
|
X
|
X
|
X
|
X
|
X
|
X
|
X
|
X
|
Dactylitis count
|
X
|
X
|
X
|
X
|
X
|
X
|
X
|
X
|
Psoriasis assessment (PASI and BSA)
|
X
|
X
|
X
|
X
|
X
|
X
|
X
|
X
|
Physician VAS
|
X
|
X
|
X
|
X
|
X
|
X
|
X
|
X
|
Metrology with BASMI (if axial involvement)
|
X
| | | |
X
| |
X
|
X
|
Patient questionnaires (VAS, HAQ, SF36, PsAID, WPAI, BASDAI, BASFI)
|
X
|
X
|
X
|
X
|
X
|
X
|
X
|
X
|
TSQM questionnaire
| |
X
|
X
|
X
|
X
|
X
|
X
|
X
|
EQ-5D-5L questionnaire
|
X
| |
X
| |
X
|
X
|
X
|
X
|
Healthcare utilisation data
| | |
X
| |
X
|
X
|
X
|
X
|
Adverse event assessments
|
X
|
X
|
X
|
X
|
X
|
X
|
X
|
X
|